MSC11FCD Therapy

· CHA University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSC11FCD Therapy, covering 2023-01-18 to 2023-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients [Phase 1, Phase 2]

See pricing